-
Infantino proposes consulting federations to reform FIFA
-
El Nino weather pattern enters record territory: scientist
-
South Africa arrests three more suspects, after nine women murdered
-
US networks halt Trump coverage in revolt over White House ban
-
Paramount settles with US states to clear Warner Bros. mega-merger
-
NOWPayments Releases Cross-Chain Payout Data Revealing Key Performance Benchmarks Across TRON, BNB Chain, and Solana
-
Climate crisis a job for world leaders, not just activists: UK FM
-
COP31 host says AI climate footprint to be a summit priority
-
COP31 host says AI's climate footprint to be a summit priority
-
Global stocks rally on lower oil prices, US-China hopes
-
EU proposes energy rating for data centres
-
Spanish PM says unregulated AI could be 'devastating'
-
TradersYard Shifts Focus to Futures Trading
-
From Korean Chipmakers to Leveraged Semiconductor ETFs: STARTRADER Launches 49 New 24/7 Stock and ETF CFDs
-
Indonesia doing 'everything' but struggling to curb fires
-
Asia stocks rise on AI, US-China trade talks optimism
-
FQ-42 Vengeance Finds New Home at Creech Air Force Base
-
France's Macron, Canada's Carney announce closer ties
-
Multi-Asset Trading Venue Monochrome Exchange Announces IEO of Its Native Token, $MCR
-
AI 'warning shots' focus Beijing on national security risks
-
Data centre command hub keeps AI up and running
-
Philippine tribe in limbo over US-led tech hub
-
Leo XIV, first US pope transcends his restrained style
-
Saudi-led coalition says Houthis fired ballistic missile at Riyadh
-
France's debt climbs to highest since 1978: ministry
-
Cuba works to restore power after another blackout
-
Thousands protest inaction over climate crisis in Switzerland
-
Brigitte Bardot widower slams sale of star's belongings
-
UK actor Naomi Watts honoured at Spain film festival
-
Indonesia accepts Malaysia's help to tackle wildfires
-
Trump signs bill authorizing sweeping Russia sanctions
-
Nvidia, OpenAI CEOs to attend Xi dinner at White House
-
Anthropic picks Accenture for in-house AI safety evaluation
-
Cuba hit with seventh major blackout of the year
-
Hushing and hedging: US companies retreat on climate
-
Nigeria miners struggled to breathe in cell before 37 died: survivors
-
Crisis-wracked Volkswagen warns of 10-bn-euro hit to profits
-
Warren Buffett steps down as Berkshire Hathaway chairman
-
Shakira to cap off world tour with Madrid 12-gig run
-
Isolated Syrian-Druze city blames Damascus for shortages
-
Isolated Syrian-Druze city shortages
-
Kerry James Marshall: American 'blackness' painter celebrated in Europe
-
UNESCO can be 'moderator' in AI debate: chief to AFP
-
Infantino 'must go', says German FA vice-president
-
Russia seizes assets of Nestle, French firms
-
Japan's busiest rail station tests robot bins
-
Anthropic says AI systems moving towards building themselves
-
Backpackers fret over Australian visa crackdown
-
Asian stocks boosted by falling oil, yen weakens after BoJ rate hike
-
Bank of Japan hikes rates to 31-year high to battle inflation
Johnson & Johnson faces UK lawsuit over talc cancer claim
Thousands of UK claimants have filed legal action against US pharmaceutical and cosmetics giant Johnson & Johnson alleging people diagnosed with cancers were exposed to asbestos in its talcum powder, lawyers said Thursday.
The company has faced a series of similar lawsuits in North America, with the latest UK claim filed in the High Court in London.
The law firm representing around 3,000 complainants in Britain said the compensation claim "is estimated to be more than £1 billion" ($1.3 billion).
They allege that either they or a family member developed forms of ovarian cancer or mesothelioma from using J&J's Baby Powder.
"The claim, which covers the period from 1965 to 2023, details how Johnson & Johnson knew that their talc products contained carcinogenic fibres, including asbestos, for more than 50 years," KP Law said.
The company "chose to keep it on the market in the pursuit of profit," it added, claiming J&J only withdrew their mineral talc from Britain in 2023, three years after it was taken off North American shelves.
A Johnson & Johnson spokesperson referred enquiries to its former consumer health arm Kenvue, which it separated from in August 2023.
"As a part of that separation, Kenvue retained the responsibility and any purported liability for talc related litigation outside of the United States and Canada," the spokesperson said.
A Kenvue spokesperson said the safety of J&J's Baby Powder "is backed by years of testing by independent and leading laboratories, universities, and health authorities in the UK and around the world".
The spokesperson added "the high-quality cosmetic grade talc" used in the powder "was compliant with any required regulatory standards, did not contain asbestos, and does not cause cancer".
US courts in April rejected a J&J offer to pay approximately $8 billion over 25 years to settle around 90,000 civil complaints there related to ovarian issues, without admitting liability.
The World Health Organization's cancer agency classified talc as "probably carcinogenic" for humans in July last year.
A summary of studies published in 2020 covering 250,000 women in the United States did not find a statistical link between the use of talc on the genitals and the risk of ovarian cancer.
M.P.Jacobs--CPN